(S (NP-SBJ (JJ Naive) (-LRB- -LRB-) (JJ CD45RA+) (-RRB- -RRB-) (NN T) (NNS lymphocytes)) (VP (VBP are) (ADJP-PRD (ADJP (RBR more) (JJ sensitive) (PP (TO to) (NP (ADJP (JJ oxidative) (JJ stress-induced)) (NNS signals)))) (PP (IN than) (NP (NN memory) (-LRB- -LRB-) (JJ CD45RO+) (-RRB- -RRB-) (NNS cells))))) (. .))
(S (S (NP-SBJ-54 (NP (NN Formation)) (PP (IN of) (NP (NP (JJ reactive) (NN oxygen) (NNS intermediates)) (PRN (-LRB- -LRB-) (NP (NN ROI)) (-RRB- -RRB-)))) (PP-TMP (IN after) (NP (JJ oxidative) (NN stress)))) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (S (NP-SBJ (-NONE- *-54)) (VP (TO to) (VP (VB be) (NP-PRD (NP (DT an) (NN activation) (NN signal)) (PP (IN for) (NP (NN T) (NNS lymphocytes))))))) (, ,) (S (ADVP (FW e.g.)) (, ,) (NP-SBJ-55 (NP (NN expression)) (PP (IN of) (NP-COOD (NP (NN IL-2)) (CC and) (NP (PRP$ its) (NN receptor))))) (VP (VBP are) (VP (VBN induced) (NP (-NONE- *-55))))))))) (. .)))
(S (NP-SBJ-56 (DT These) (JJ ROI-induced) (NNS effects)) (VP (MD can) (, ,) (PP (TO to) (NP (DT a) (JJ large) (NN extent))) (, ,) (VP (VB be) (VP (VBN attributed) (NP (-NONE- *-56)) (PP (TO to) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (DT the) (NN transcription) (NN factor) (NN NF-kappaB)))))))) (. .))
(S (ADVP-TMP (RB Now)) (NP-SBJ (PRP we)) (VP (VBP have) (VP (VBN examined) (SBAR (IN whether) (S (NP-SBJ (UCP-COOD (ADJP (JJ naive)) (CC and) (NP (NN memory))) (NN T) (NNS lymphocytes)) (VP (VBP differ) (PP (IN in) (NP (NP (PRP$ their) (NN sensitivity)) (PP (TO to) (NP (JJ ROI-mediated) (NNS signals)))))))))) (. .))
(S (S-COOD (SBAR-TMP (WHADVP-57 (WRB When)) (S (NP-SBJ-58 (ADJP-COOD (ADJP (ADJP (JJ CD45RA+)) (PRN (-LRB- -LRB-) (ADJP (JJ naive)) (-RRB- -RRB-))) (CC and) (ADJP (ADJP (JJ CD45RO+)) (PRN (-LRB- -LRB-) (NP (NN memory)) (-RRB- -RRB-)))) (NN T) (NNS lymphocytes)) (VP (VBD were) (VP (ADVP (RB directly)) (VBN stimulated) (NP (-NONE- *-58)) (PP (IN with) (NP (NN H2O2))) (ADVP (-NONE- *T*-57)))))) (, ,) (NP-SBJ (NN NF-kappaB) (JJ nuclear) (NN translocation)) (VP (VBD was) (ADJP-PRD (ADJP (JJR stronger)) (PP (-NONE- *ICH*-109))) (PP (IN in) (NP (JJ naive) (NNS cells))) (PP-109 (IN than) (FRAG (PP (IN in) (NP (NN memory) (NNS cells))))))) (CC and) (S (NP-SBJ-59 (PRP it)) (VP (MD could) (VP (VB be) (VP (VBN induced) (NP (-NONE- *-59)) (PP (IN with) (NP (JJR lower) (NNS doses))))))) (. .))
(S (NP-SBJ (NP (NP (DT The) (NN composition)) (PP (IN of) (NP (DT the) (VBN induced) (JJ nuclear) (NN NF-kappaB)))) (PRN (-LRB- -LRB-) (NP (NP (NNS levels)) (PP (IN of) (NP (NP-COOD (NP (NN p50)) (CC and) (NP (NN RelA))) (NNS proteins)))) (-RRB- -RRB-))) (VP (VBD was) (ADJP-PRD (JJ similar)) (PP (IN in) (NP (DT these) (NN cell) (NNS types)))) (. .))
(S (NP-SBJ (NP (DT The) (NP-COOD (NP (NN magnitude)) (CC and) (NP (NNS kinetics)))) (PP (IN of) (NP (JJ intracellular) (NN ROI)))) (VP (VBD were) (ADJP-PRD (JJ similar)) (, ,) (S (NP-SBJ (-NONE- *)) (VP (VBG suggesting) (SBAR (IN that) (S (NP-SBJ (EX there)) (VP (VBD were) (NP-PRD (DT no) (NNS differences)) (PP (IN in) (NP-COOD (NP (JJ ROI-forming) (NNS mechanisms)) (CC or) (NP (JJ antioxidative) (NNS capacities)))))))))) (. .))
(S (S (NP-SBJ (DT The) (JJ probable) (JJ regulatory) (NN point)) (VP (VBD was) (NP-PRD (DT the) (JJ cytoplasmic) (NN IkappaB) (NN inhibitor))) (: :)) (S (PP (IN in) (NP (JJ CD45RA+) (NNS cells))) (, ,) (NP-SBJ (NN H2O2)) (VP (VBD caused) (NP (NP (DT a) (ADJP (RBR more) (JJ profound)) (NN depression)) (PP (IN in) (NP (NP (DT the) (NNS levels)) (PP (IN of) (NP (NN IkappaB) (NN alpha))))))) (. .)))
(S (NP-SBJ (DT These) (NNS findings)) (VP (VBP indicate) (SBAR (IN that) (S (NP-SBJ (NP (NN T) (NNS cells)) (VP (VBG representing) (NP (JJ different) (NP-COOD (NP (NN activation)) (CC (or and)) (NP (NN differentiation))) (NNS stages)))) (VP (MD can) (VP (VB be) (ADJP-PRD (RB differentially) (JJ responsive) (PP (TO to) (NP (JJ ROI-mediated) (NNS signals))))))))) (. .))
